BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29664669)

  • 1. Primary Nonsecretory Plasma Cell Leukemia With Multiple Chromosomal Abnormalities: A Case Report.
    Nakayama S; Oda T; Minabe S; Bamba Y; Ukawa H; Sato R; Kawabata M; Horiuchi T; Watanabe J; Kimura F; Shimazaki H; Ogata S; Nakanishi K
    Arch Iran Med; 2018 Jan; 21(1):41-43. PubMed ID: 29664669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Plasma Cell Leukemia Associated with t(6;14)(p21;q32) and IGH Rearrangement: A Case Study and Review of the Literature.
    Cho SY; Lim G; Oh SH; Lee HJ; Suh JT; Lee J; Lee WI; Lee HG; Yoon HJ; Park TS
    Ann Clin Lab Sci; 2011; 41(3):277-81. PubMed ID: 22075513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligosecretory Primary Plasma Cell Leukemia with Atypical Morphological Abnormality.
    Toriyama E; Imaizumi Y; Tsuruda K; Itonaga H; Sato S; Ando K; Sawayama Y; Hasegawa H; Hata T; Niino D; Yanagihara K; Miyazaki Y
    Intern Med; 2019 Aug; 58(15):2213-2217. PubMed ID: 30996175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau H; Li JY; Facon T; Brigaudeau C; Morineau N; Maloisel F; Rapp MJ; Talmant P; Trimoreau F; Jaccard A; Harousseau JL; Bataille R
    Cancer Res; 1998 Dec; 58(24):5640-5. PubMed ID: 9865713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic aberrations in plasma cell leukemia shown by interphase fluorescence in situ hybridization.
    Chang H; Sloan S; Li D; Patterson B
    Cancer Genet Cytogenet; 2005 Jan; 156(2):150-3. PubMed ID: 15642395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.
    Kalff A; Khong T; Wall M; Gorniak M; Mithraprabhu S; Campbell LJ; Spencer A
    Haematologica; 2015 Feb; 100(2):e60-2. PubMed ID: 25381133
    [No Abstract]   [Full Text] [Related]  

  • 7. Light-chain plasma cell myeloma caused by 14q32/IGH translocation and loss of the other allele.
    Nishio Y; Sakai H; Saiki Y; Uchida A; Uemura Y; Matsunawa M; Isobe Y; Kato M; Tomita N; Miura I
    Int J Hematol; 2019 May; 109(5):572-577. PubMed ID: 30887274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsecretory plasma cell myeloma--becoming even more rare with serum free light-chain assay: a brief review.
    Shaw GR
    Arch Pathol Lab Med; 2006 Aug; 130(8):1212-5. PubMed ID: 16879026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia.
    Bladé J; Kyle RA
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1259-72. PubMed ID: 10626149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of illegitimate rearrangements within the immunoglobulin light chain loci in B cell malignancies using end sequenced probes.
    Poulsen TS; Silahtaroglu AN; Gisselø CG; Tommerup N; Johnsen HE
    Leukemia; 2002 Oct; 16(10):2148-55. PubMed ID: 12357370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-random chromosomal rearrangements and their implications in clinical features and outcome of multiple myeloma and plasma cell leukemia.
    Taniwaki M; Nishida K; Ueda Y; Takashima T
    Leuk Lymphoma; 1996 Mar; 21(1-2):25-30. PubMed ID: 8907265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 14q+ marker chromosome due to t(11;14) in a case of nonsecretory plasma cell leukemia].
    Fukushima Y; Miura I; Niitsu H; Hashimoto K; Takatsu H; Akihama T; Miura A
    Rinsho Ketsueki; 1986 Nov; 27(11):2124-30. PubMed ID: 3820630
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene.
    Ohbayashi K; Taniwaki M; Ninomiya M; Kiyoi H; Iida S; Ueda R; Naoe T
    Cancer Genet Cytogenet; 2003 Jul; 144(1):31-5. PubMed ID: 12810253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of IGH/CCND1 fusion gene in a primary plasma cell leukemia case.
    Ishigaki T; Sasaki K; Watanabe K; Nakamura N; Toyota S; Kobayashi H; Tohda S
    Cancer Genet Cytogenet; 2010 Aug; 201(1):62-5. PubMed ID: 20633772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent upregulation of MYC in plasma cell leukemia.
    Chiecchio L; Dagrada GP; White HE; Towsend MR; Protheroe RK; Cheung KL; Stockley DM; Orchard KH; Cross NC; Harrison CJ; Ross FM;
    Genes Chromosomes Cancer; 2009 Jul; 48(7):624-36. PubMed ID: 19396865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive primary plasma cell leukemia with skin manifestations, trisomy 8 and molecular oligoclonal features.
    Robak T; Urbańska-Rys H; Robak E; Bartkowiak J; Strzelecka B; Biernat W; Kordek R
    Leuk Lymphoma; 2002 May; 43(5):1067-73. PubMed ID: 12148888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase FISH assays for the detection of translocations with breakpoints in immunoglobulin light chain loci.
    Martín-Subero JI; Harder L; Gesk S; Schlegelberger B; Grote W; Martinez-Climent JA; Dyer MJ; Novo FJ; Calasanz MJ; Siebert R
    Int J Cancer; 2002 Mar; 98(3):470-4. PubMed ID: 11920602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique.
    Avet-Loiseau H; Daviet A; Brigaudeau C; Callet-Bauchu E; Terré C; Lafage-Pochitaloff M; Désangles F; Ramond S; Talmant P; Bataille R
    Blood; 2001 Feb; 97(3):822-5. PubMed ID: 11157506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.